Format

Send to

Choose Destination
Australas J Dermatol. 2014 May;55(2):128-31. doi: 10.1111/ajd.12136. Epub 2014 Jan 23.

Moderate to severe hidradenitis suppurativa treated with biological therapies.

Author information

1
Department of Dermatology, Liverpool Hospital, Liverpool, Australia.

Abstract

Hidradenitis suppurativa is a debilitating disorder that can be difficult to manage with current conventional treatment strategies. Given its association with proinflammatory cytokines there has been interest in the use of novel biological monoclonal antibodies. We describe our experience with the use of these agents in six patients in whom conventional treatment had failed, with promising response noted in some patients. A growing number of studies now highlight the efficacy of these agents.

KEYWORDS:

biological therapy; hidradenitis suppurativa; monoclonal antibody

PMID:
24456051
DOI:
10.1111/ajd.12136
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center